STAT December 21, 2023
Elizabeth Cooney

Good morning. Don’t miss Nicholas Florko’s jaw-dropping investigation into medical marijuana businesses marketing their products for cancer or depression with no regulatory oversight.

Medical marijuana companies are following pharma’s playbook, except for the rules

Medical marijuana companies borrow a lot of marketing tactics from pharmaceutical companies. But because they don’t follow the same rules, patients are put at risk, STAT’s Nicholas Florko tells us in a new STAT investigation. Big players like Trulieve, Curaleaf, and Verano advertise their products as treatments not just for muscle aches, but for cancer and depression, without evidence to back up those claims.

How can they get away with this? Therein lies the paradox: Cannabis companies don’t have to abide by rules over the claims...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Pharma / Biotech, Pricing / Spending
The CMS NHE 2023 Report: An Incomplete Picture at a Pivotal Time
Podcast: Holly Jolly Health Expenditures
U.S. Health Care Spending Reaches $4.9 Trillion
National Health Spending Explorer - 2
How has U.S. Spending on Health Care Changed Over Time?

Share This Article